Table 3.
Pathway Names | P values | FDR |
---|---|---|
GACAATC,MIR-219 | 1.41E-08 | 9.52E-05 |
NUCLEAR_UBIQUITIN_LIGASE_COMPLEX | 2.16E-07 | 0.00073 |
YRCCAKNNGNCGC_UNKNOWN | 7.11E-07 | 0.0016 |
V$E2F_Q2 | 9.88E-07 | 0.001668 |
NEURON_PROJECTION | 1.37E-05 | 0.015893 |
V$GABP_B | 1.41E-05 | 0.015893 |
TOMLINS_METASTASIS_DN | 1.66E-05 | 0.015965 |
JAEGER_METASTASIS_UP | 3.34E-05 | 0.018801 |
NUCLEOBASENUCLEOSIDENUCLEOTIDE_KIN ASE_ACTIVITY |
2.74E-05 | 0.018801 |
RUIZ_TNC_TARGETS_DN | 2.99E-05 | 0.018801 |
SUGAR_BINDING | 2.71E-05 | 0.018801 |
V$E2F_Q4 | 3.27E-05 | 0.018801 |
CARBOHYDRATE_BINDING | 4.87E-05 | 0.024581 |
UBIQUITIN_LIGASE_COMPLEX | 5.10E-05 | 0.024581 |
V$E2F_Q6 | 5.64E-05 | 0.025396 |
LIPID_KINASE_ACTIVITY | 6.62E-05 | 0.027946 |
V$FREAC7_01 | 7.88E-05 | 0.031284 |
CAGCTTT,MIR-320 | 0.000106 | 0.033841 |
DAZARD_RESPONSE_TO_UV_NHEK_UP | 0.000101 | 0.033841 |
HALMOS_CEBPA_TARGETS_DN | 9.54E-05 | 0.033841 |
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_ UP |
0.00011 | 0.033841 |
TAGHAVI_NEOPLASTIC_TRANSFORMATION | 0.000107 | 0.033841 |
COLLER_MYC_TARGETS_UP | 0.000116 | 0.034047 |
V$AML_Q6 | 0.000138 | 0.038786 |
REACTOME_CALCITONIN_LIKE_LIGAND_RE CEPTORS |
0.00017 | 0.045858 |
AMIT_EGF_RESPONSE_480_HELA | 0.000182 | 0.04725 |
BIOCARTA_CTCF_PATHWAY | 0.000253 | 0.047743 |
BIOCARTA_RAC1_PATHWAY | 0.0002 | 0.047743 |
CTCTATG,MIR-368 | 0.000226 | 0.047743 |
GNF2_SPINK1 | 0.000219 | 0.047743 |
IIZUKA_LIVER_CANCER_PROGRESSION_L0_L 1_UP |
0.000242 | 0.047743 |
IVANOVA_HEMATOPOIESIS_LATE_PROGENIT OR |
0.000263 | 0.047743 |
module_320 | 0.000223 | 0.047743 |
MUELLER_COMMON_TARGETS_OF_AML_FU SIONS_DN |
0.000246 | 0.047743 |
REACTOME_ACTIVATION_OF_NMDA_RECEP | 0.000263 | 0.047743 |
TOR_UPON_GLUTAMATE_BINDING_AND_PO STSYNAPTIC_EVENTS |
||
RESPONSE_TO_STEROID_HORMONE_STIMUL US |
0.000269 | 0.047743 |
SCGGAAGY_V$ELK1_02 | 0.000241 | 0.047743 |
V$E47_01 | 0.000207 | 0.047743 |
CELLULAR_BIOSYNTHETIC_PROCESS | 0.000294 | 0.048217 |
DAZARD_RESPONSE_TO_UV_SCC_DN | 0.000296 | 0.048217 |
REGULATION_OF_CELLULAR_PROTEIN_MET ABOLIC_PROCESS |
0.0003 | 0.048217 |
V$ZF5_01 | 0.000283 | 0.048217 |
GAGACTG,MIR-452 | 0.000334 | 0.050215 |
KAPOSI_LIVER_CANCER_POOR_SURVIVAL_U P |
0.000342 | 0.050215 |
MORF_BRCA1 | 0.00034 | 0.050215 |
PACHER_TARGETS_OF_IGF1_AND_IGF2_UP | 0.000341 | 0.050215 |
chr4q26 | 0.000363 | 0.052097 |
BIOCARTA_MCM_PATHWAY | 0.000395 | 0.054476 |
GGCACAT,MIR-455 | 0.000391 | 0.054476 |
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION _UP |
0.000423 | 0.056037 |
SENESE_HDAC1_AND_HDAC2_TARGETS_DN | 0.000415 | 0.056037 |
CTCNANGTGNY_UNKNOWN | 0.000445 | 0.056717 |
REGULATION_OF_PROTEIN_METABOLIC_PR OCESS |
0.000437 | 0.056717 |
BIOCARTA_RAS_PATHWAY | 0.000475 | 0.057752 |
chr10q23 | 0.000468 | 0.057752 |
module_321 | 0.00048 | 0.057752 |
V$NRF2_01 | 0.000488 | 0.057752 |
KENNY_CTNNB1_TARGETS_DN | 0.000518 | 0.060337 |
chr2q13 | 0.000568 | 0.064501 |
REGULATION_OF_CELL_CYCLE | 0.000573 | 0.064501 |
GNF2_SERPINI2 | 0.000604 | 0.066831 |
V$T3R_Q6 | 0.00066 | 0.071888 |
ACCGAGC,MIR-423 | 0.000686 | 0.073179 |
HELLER_HDAC_TARGETS_UP | 0.000694 | 0.073179 |
LEE_DIFFERENTIATING_T_LYMPHOCYTE | 0.000712 | 0.073942 |
CHESLER_BRAIN_HIGHEST_EXPRESSION | 0.00079 | 0.080012 |
MATSUDA_NATURAL_KILLER_DIFFERENTIA TION |
0.000794 | 0.080012 |
MICROTUBULE_MOTOR_ACTIVITY | 0.000807 | 0.080139 |
AGGGCCA,MIR-328 | 0.000836 | 0.081055 |
HOFMANN_CELL_LYMPHOMA_DN | 0.000841 | 0.081055 |
CYTOSKELETAL_PART | 0.000873 | 0.082976 |
CYTOSKELETON | 0.00092 | 0.085062 |
OHM_EMBRYONIC_CARCINOMA_UP | 0.000909 | 0.085062 |
CAGCCTC,MIR-485-5P | 0.000934 | 0.085164 |
PROTEIN_UBIQUITINATION | 0.000992 | 0.089296 |
chr9q22 | 0.001106 | 0.096946 |
FERREIRA_EWINGS_SARCOMA_UNSTABLE_V S_STABLE_DN |
0.001105 | 0.096946 |